NMR diffusion and relaxation study on ibuprofen-HSA interaction

Applied Spectroscopy

Volumn 53, Issue 7, 1999, Pages 776-779

  Luo, Ren Sheng ^a   Liu, Mai Li ^a   Mao, Xi An ^a  

^a Chinese Academy of Sciences   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING ENERGY; DIFFUSION; DRUG INTERACTIONS; DRUG PRODUCTS; ION EXCHANGE; MOLECULAR DYNAMICS; PROTEINS; RELAXATION PROCESSES;

HUMAN SERUM ALBUMIN; IBUPROFEN;

NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY;

EID: 0032679466     PISSN: 00037028     EISSN: None     Source Type: Journal    
DOI: 10.1366/0003702991947559     Document Type: Article

References (24)

1. R. E. Hurd, in Encyclopedia of Nuclear Magnetic Resonance, D. M. Grant and R. K. Harris, Eds. (Wiley, New York, 1995), pp. 1990-2005.
2. M. L. Liu, J. K. Nicholson, and J. C. Lindon, Anal. Commun. 34, 225 (1997).
3. Y. H. Ma, M. L. Liu, X.-A. Mao, J. K. Nicholson, and J. C. Lindon, Magn. Reson. Chem., paper in press.
4. N. Hamasaki and Z. B. Rose, J. Biol. Chem. 249, 7896 (1974).
5. A. L. Lennon, N. R. Scott, B. E. Chapman, and P. W. Kuchel, Biophys. J. 67, 2096 (1994).
6. A. L. Lennon, B. E. Chapman, and P. W. Kuchel, Bull. Magn. Reson. 17, 1 (1995).
7. For example, see J. Kaerger, Ann. Phys. 24, 1 (1969).
8. T. Itoh, Y. Saura, Y. Tsuda, and H. Yamada, Chirality 9, 643 (1997).
9. D. S. Hage, T. A. G. Noctor, and I. W. Wainer, J. Chromat. 693, 23 (1995).
10. V. K. Cheruvallath, C. M. Riley, S. R. Narayanan, S. Lindenbaum, and J. H. Perrin, J. Pharm. Biomed. Anal. 115, 1719 (1997).
11. J. Oravcova, V. Mlynarik, S. Bystricky, L. Soltes, P. Szalay, L. Bohacik, and T. Trnovec, Chirality 3, 412 (1991).
12. M. H. Rahman, K. Yamasaki, Y. H. Shin, C. C. Lin, and M. Otagiri, Bio. Pharm. Bull. 16, 1169 (1993).
13. D. E. Epps, T. J. Raub, and F. J. Kezdy, Anal. Biochem. 227, 342 (1995).
14. D. Wu, A. Chen, and C. S. Johnson, Jr., J. Magn. Reson. Ser. A 115, 260 (1995).
15. X.-A. Mao and C. H. Ye, Chem. Phys. Lett. 227, 645 (1994).
16. A. Abragam, The Principles of Nuclear Magnetism (Clarendon, Oxford, 1961).
17. X. M. He and D. C. Carter, Nature 358, 209 (1992).
18. N. Okabe and N. Hashizume, Biol. Pharmac. Bull. 17, 16 (1994).
19. A. F. Aubry, N. Markoglou, and A. McGann, Compar. Biochem. Physiol. C-Pharm. Toxic. Endocr. 112, 257 (1995).
20. A. Sulkowska, Appl. Spectrosc. 51, 428 (1997).
21. T. Peters, Jr., Adv. Protein Chem. 37, 161 (1985).
22. D. C. Carter and J. X. Ho, Adv. Protein Chem. 45, 153 (1994).
23. S. Aime, M. Botta, M. Fasano, S. G. Crich, and E. Terreno, J. Bioinorg. Chem. 1, 312 (1996).
24. V. Andrisano, T. D. Booth, V. Cavrini, and I. W. Wainer, Chirality 9, 178 (1997).